A Multi-center,Double-blind,Randomized Controlled Study on Xiao’er Qingfei Granules(小儿清肺颗粒) in Treating Children Acute Bronchitis with Syndrome of Phlegm-Heat Obstructing Lung
|更新时间:2021-11-10
|
A Multi-center,Double-blind,Randomized Controlled Study on Xiao’er Qingfei Granules(小儿清肺颗粒) in Treating Children Acute Bronchitis with Syndrome of Phlegm-Heat Obstructing Lung
Journal of Traditional Chinese MedicineVol. 61, Issue 17, Pages: 1530-1535(2020)
LIU Kun, JI Xiaohua, CAI Jianxin, et al. A Multi-center,Double-blind,Randomized Controlled Study on Xiao’er Qingfei Granules(小儿清肺颗粒) in Treating Children Acute Bronchitis with Syndrome of Phlegm-Heat Obstructing Lung[J]. Journal of Traditional Chinese Medicine2020, 61(17): 1530-1535.
LIU Kun, JI Xiaohua, CAI Jianxin, et al. A Multi-center,Double-blind,Randomized Controlled Study on Xiao’er Qingfei Granules(小儿清肺颗粒) in Treating Children Acute Bronchitis with Syndrome of Phlegm-Heat Obstructing Lung[J]. Journal of Traditional Chinese Medicine2020, 61(17): 1530-1535.DOI: 10.13288/j.11-2166/r.2020.17.014.
A Multi-center,Double-blind,Randomized Controlled Study on Xiao’er Qingfei Granules(小儿清肺颗粒) in Treating Children Acute Bronchitis with Syndrome of Phlegm-Heat Obstructing Lung
Objective To evaluate the efficacy and safety of Xiao′er Qingfei Granules(小儿清肺颗粒) in treating children acute bronchitis with syndrome of phlegm-heat obstructing lung. Methods The stratified blocked randomization
positive drug parallel contrast
double blind
double dummy
non inferiority test
and multi-centered research were applied to this study. A total of 240 cases were divided into a treatment group and a control group
with 120 cases in each group. The treatment group was given oral Xiao′er Qingfei Granules and Jizhi Syrup(急支糖浆) simulator
and the control group was given Jizhi Syrup and Xiao′er Qingfei Granules Simulator. The course of treatment for both groups was 5 days. After treatment
the disappearance time of the main symptoms(cough
expectoration)
the onset time of antitussive
the efficacy of the disease
the efficacy of traditional Chinese medicine(TCM) syndromes
the time for complete fever reduction and safety were evaluated. Results There was no statistically significant difference between groups in main symptoms(cough
expectoration) disappeared time
cough onset time and complete antipyretic time(P
>
0.05). After non-inferiority test
the therapeutic effects of the treatment group was not inferior to that of the control group
and the two groups had similar effects. After 5 days of treatment
the effective rates of TCM syndromes in the treatment group and the control group reached 98.33% and 92.37% respectively. The difference between groups in the full analysis data set(FAS) was statistically significant(P
FAS
=0.0285)
suggesting the treatment group was better than the control group in improving symptoms. There was no significant difference in adverse reactions between groups(P
>
0.05). Conclusion Xiao′er Qingfei Granules has satisfactory effects on children acute bronchitis with syndrome of phlegm-heat obstructing lung
which is in line with those of Jizhi Syrup. In terms of TCM syndrome improving
Methodological Issues in the Design,Evaluation,and Reporting of Randomized Controlled Trials with "Pattern Dominating Disease"
Effect of Electroacupuncture on Metabolism-Inflammation Network in Patients with Simple Obesity:A Randomized Controlled Trial
Acupuncture Treatment for Severe Bell's Palsy and Its Impact on Serum GDNF and NGF:A Randomized Controlled Trial
Effect of Heat-sensitive Moxibustion on Quality of Life and Immune Function in Non-Small Cell Lung Cancer Patients with Qi Deficiency and Phlegm Stasis Syndrome Undergoing Chemotherapy:A Randomized Controlled Trial
Current Status and Strategic Recommendations for Randomized Controlled Trials on Functional Dyspepsia-Irritable Bowel Syndrome Comorbidity:from a Real-World Research Perspective
Related Author
WANG Lu
WANG Jiajia
ZHANG Yingying
LUO Xufei
CHEN Yaolong
LI Jiansheng
SHU Qi
PENG Qiumei
Related Institution
Lung Disease Diagnosis and Treatment,The First Affiliated Hospital of Henan University of Chinese Medicine
Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases Co-constructed by Henan Province Education Ministry of P.R.China/Henan Key Laboratory of Chinese Medicine for Respiratory Diseases,Henan University of Chinese Medicine
School of Chinese Medicine,Hong Kong Baptist University
Research Unit of Evidence-Based Evaluation and Guidelines,Chinese Academy of Medical Sciences,School of Basic Medical Sciences,Lanzhou University
Key Laboratory of Evidence Based Medicine of Gansu Province